PHARMACEUTICAL COMPOSITION COMPRISING (S)-(+)-3-[1-[2-(1-ACETYL-2,3-DIHYDRO-1H-INDOL-3-YL)ETHYL]-1,2,3,6-TETRAHYDROPYRIDIN-4-YL]-6-CHLORO-1H-INDOLE

Rene Holm

PHARMACEUTICAL COMPOSITION COMPRISING (S)-(+)-3-[1-[2-(1-ACETYL-2,3-DIHYDRO-1H-INDOL-3-YL)ETHYL]-1,2,3,6-TETRAHYDROPYRIDIN-4-YL]-6-CHLORO-1H-INDOLE

Rene Holm (Opfinder)

Lundbeck A/S

Publikation: Patent

Abstract

A pharmaceutical composition comprising a melt granulate, comprising (S)-(+)-3-[1-[2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl]-6-chloro-1H-indole or a pharmaceutically acceptable salt thereof. The active compound has an effect at dopamine D4 receptors and is useful in the treatment of e.g. schizophrenia, anxiety disorder, depression, aggression and senile dementia.

Originalsprog	Engelsk
IPC	A61K 31/ 4439 A I
Patentnummer	WO2004004717
Land/Område	Danmark
Prioritetsdato	05/07/2002
Prioritetsnummer	DK2002PA01064
Status	Udgivet - 15. jan. 2004
Udgivet eksternt	Ja

SDU link

Tjek adgangen til materialet i Syddansk Universitetsbiblioteks søgemaskine

Citationsformater

@misc{98911c031f8449fc9ef59684c21bffd7,

title = "PHARMACEUTICAL COMPOSITION COMPRISING (S)-(+)-3-[1-[2-(1-ACETYL-2,3-DIHYDRO-1H-INDOL-3-YL)ETHYL]-1,2,3,6-TETRAHYDROPYRIDIN-4-YL]-6-CHLORO-1H-INDOLE",

abstract = "A pharmaceutical composition comprising a melt granulate, comprising (S)-(+)-3-[1-[2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl]-6-chloro-1H-indole or a pharmaceutically acceptable salt thereof. The active compound has an effect at dopamine D4 receptors and is useful in the treatment of e.g. schizophrenia, anxiety disorder, depression, aggression and senile dementia.",

author = "Rene Holm",

year = "2004",

month = jan,

day = "15",

language = "English",

type = "Patent",

note = "WO2004004717; A61K 31/ 4439 A I",

}

TY - PAT

T1 - PHARMACEUTICAL COMPOSITION COMPRISING (S)-(+)-3-[1-[2-(1-ACETYL-2,3-DIHYDRO-1H-INDOL-3-YL)ETHYL]-1,2,3,6-TETRAHYDROPYRIDIN-4-YL]-6-CHLORO-1H-INDOLE

AU - Holm, Rene

PY - 2004/1/15

Y1 - 2004/1/15

N2 - A pharmaceutical composition comprising a melt granulate, comprising (S)-(+)-3-[1-[2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl]-6-chloro-1H-indole or a pharmaceutically acceptable salt thereof. The active compound has an effect at dopamine D4 receptors and is useful in the treatment of e.g. schizophrenia, anxiety disorder, depression, aggression and senile dementia.

AB - A pharmaceutical composition comprising a melt granulate, comprising (S)-(+)-3-[1-[2-(1-acetyl-2,3-dihydro-1H-indol-3-yl)ethyl]-1,2,3,6-tetrahydropyridin-4-yl]-6-chloro-1H-indole or a pharmaceutically acceptable salt thereof. The active compound has an effect at dopamine D4 receptors and is useful in the treatment of e.g. schizophrenia, anxiety disorder, depression, aggression and senile dementia.

M3 - Patent

M1 - WO2004004717

ER -

PHARMACEUTICAL COMPOSITION COMPRISING (S)-(+)-3-[1-[2-(1-ACETYL-2,3-DIHYDRO-1H-INDOL-3-YL)ETHYL]-1,2,3,6-TETRAHYDROPYRIDIN-4-YL]-6-CHLORO-1H-INDOLE

Abstract

SDU link

Fingeraftryk

Citationsformater